GeneTelligence ApS: Financial statements 2022
CVR: 37669741
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
GeneTelligence ApS (CVR 37669741) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -895,750 and a net result of DKK -2,206,052 compared with DKK -704,763 the year before. Equity in the 2022 report amounted to DKK -3,693,392. The company had 2 employees in the financial year.
- Gross Profit
- DKK -895,750
- Profit/Loss
- DKK -2,206,052
- Equity
- DKK -3,693,392
- Total Assets
- DKK 2,027,197
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -896 t. | -2.2 mio. | -3.7 mio. | 2 |
| 2021 | - | -41 t. | -705 t. | -2 mio. | 2 |
| 2020 | 602 t. | -413 t. | -2 mio. | -2.3 mio. | 2 |
| 2019 | 167 t. | -1.2 mio. | -2.4 mio. | -1.1 mio. | 2 |
| 2018 | 254 t. | 195 t. | -311 t. | 3.1 mio. | 1 |
Official annual report
Keep an eye on GeneTelligence ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
GeneTelligence ApS has published its annual report for 2021. Gross profit came to DKK -41,205, and the net result was DKK -704,763.
About GeneTelligence ApS
GeneTelligence ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2016. The company has been dissolved on 9 December 2024. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK 536,199 and a net result of DKK -1,886,251 compared with DKK -2,206,052 the year before. Equity in the 2023 report amounted to DKK -5,579,644.